MYRG MYR GROUP INC. Insider Trading

Director Donald C.I. Lucky sold 14,675 shares for $6,596,801.60 on 2026-06-03, reducing holdings to 5,579 shares post-transaction.

Donald C.I. Lucky's four separate sales totaling 14,675 shares for $6,596,801.60 at a blended average price of $449.53 represent a substantial reduction in director stake at MYR GROUP INC. His post-transaction holdings of 5,579 shares reflect a net change of sold 14,675 shares (-72.5% vs pre-transaction holdings of 20,254 shares). The timing occurs with the stock trading at $451.40, within 6.9% of its 52-week high of $484.71, and the company reports strong recent fundamentals including FY revenue growth of +8.8% and a quarterly revenue of $1,000,380,000.00 with net income of $46,800,000.00.

Director Kenneth Hartwick sold 3,500 shares of MYRG for $1,576,750 on 2026-06-03; holds 18,631 shares post-sale

Kenneth Hartwick sold 3,500 shares of MYR GROUP INC. at $450.50, reducing his stake by approximately 15.8% from 22,131 to 18,631 shares. The stock is currently trading at $451.40, near the top of its 52-week range of $154.62–$484.71, and has appreciated 73.0% over the past 90 days. Despite this recent strength, the company trades at a elevated P/E of 49.55 with a market cap of $7,028,765,650.40. The timing of this sale during a period of strong near-term price momentum and steep valuation multiples is noteworthy for investors monitoring director-level activity at the company.

Director Shirin O'Connor sold 3,159 shares ($1.4M) at MYRG on 2026-06-01; post-sale holdings: 4,061 shares (43.8% reduction)

Shirin O'Connor executed 8 separate sales totaling 3,159 shares for $1,412,680.39 on 2026-06-01, reducing her holdings from 7,220 shares to 4,061 shares. The blended average price of $447.19 sits within the broader trading range and near current levels ($451.40), suggesting execution during normal market conditions. MYRG trades at a P/E of 49.55 with 90-day gains of +73.0%, indicating strong recent momentum. The sale represents a material reduction—43.8% of pre-transaction holdings—concentrated in a single day, which merits investor attention as a significant position adjustment for a board member at a high-multiple equity.

CFO Kelly Michelle Huntington sold 2,000 shares (29.9% of holdings) for $915,315.25 at MYRG on 2026-06-01.

Kelly Michelle Huntington, Senior VP and CFO, executed 5 separate sales totaling 2,000 shares for $915,315.25 across a narrow price range (blended average $457.66), reducing her holdings from 6,691 to 4,691 shares—a 29.9% reduction. The sale occurred at prices substantially above the current price of $451.40 and near the 52-week high of $484.71. Her cross-ticker track record shows strong prior timing (2 prior buys with 100% 90-day win rate and +66.8% average 90-day return), and her same-ticker history at MYRG includes two prior purchases in 2024 that were both well-timed on the 90-day horizon. However, this represents her first sale at MYRG and the first open-market sale in her visible insider history across all tickers, eliminating any basis for comparison to her prior directional patterns. The absence of any sell history, combined with a significant reduction in her equity exposure, represents a notable shift from her established buying posture.

SVP and COO Egan sells 2,900 shares for $676,860.60 at blended average of $233.40, reducing holdings by 33.3%

Egan Don A., SVP and COO of C&I, executed 2 separate sales totaling 2,900 shares for $676,860.60 on 2025-11-04 at a blended average price of $233.40. This sale reduced his holdings by 33.3%, from 8,697 shares to 5,797 shares—a material reduction in position size. The sale occurred as MYRG trades at $235.79, near its 52-week high of $235.79, and following strong recent momentum (30-day change: +18.1%, 90-day change: +27.0%). However, the company's fundamentals show annual revenue growth of -7.7%, and the P/E of 37.43 reflects a historically elevated valuation. The sale's materiality lies in the significant liquidation of executive equity exposure during a period of strong stock appreciation and softening revenue trends.

Director Bradley Thede purchased 835 shares of MYRG at $119.60, increasing holdings to 13,542 shares; stock now trading at $124.20 (-30.3% from 52-week high).

Director Favreau Bradley Thede purchased 835 shares at $119.60 on 2025-03-04, raising his post-transaction holdings to 13,542 shares. The purchase represents a 6.6% increase in his shareholding and occurs against a backdrop of significant recent price weakness: the stock is -12.2% over 30 days and -25.4% over 90 days, though it remains -30.3% below its 52-week high of $178.21. Notably, Thede's track record at this same ticker shows one prior buy on 2024-08-27 that generated a 90-day return of +60.2%, establishing a pattern of well-timed accumulation. The timing of this purchase, following material recent declines, is the primary signal for investor attention given the director's demonstrated ability to identify favorable entry points at this specific security.

CFO Kelly Michelle bought 500 MYRG shares at $88.64; post-trade holdings 3,030 shares. Stock down 47.2% from 52-week high.

Huntington Kelly Michelle, Senior VP and CFO, purchased 500 shares of MYR GROUP INC. at $88.64 on 2024-09-09, increasing her holdings by 19.8% from 2,530 to 3,030 shares. The transaction occurs within the 52-week range ($88.59–$178.21), and at current price of $94.04, the stock is -47.2% from its 52-week high and down 34.1% over 90 days. Notably, her prior trade at MYRG (a buy on 2024-08-09) showed a negative 30-day return of -11.0%, and her cross-ticker track record reflects an average 30-day return of -11.0% on 1 prior open-market buy. The company's latest quarter shows revenue of $828.9M with a net loss of -$15.3M, alongside a P/E of 31.56, suggesting the fundamentals remain under pressure despite 21.1% annual revenue growth. The CFO's purchase at depressed price levels warrants monitoring in context of the company's negative earnings trend.

MYRG Director Favreau buys 1,005 shares at $99.70; stock down 43.9% from 52-week high, now at $100.01

Director Favreau Bradley Thede purchased 1,005 shares at $99.70 on 2024-08-27, increasing his holdings by 8.6% to 12,707 shares post-transaction. The purchase occurs in a deteriorating price environment: the stock is -43.9% from its 52-week high of $178.21 and has declined 35.5% over the past 90 days, with current price at $100.01. This represents a rare insider purchase activity at a substantially depressed valuation relative to recent trading ranges, occurring while the company reports net losses of $-15.3M in the latest quarter despite 21.1% annual revenue growth. The confluence of asset accumulation by a director at a cyclical trough alongside negative quarterly earnings and steep drawdowns invites scrutiny of whether this reflects calculated entry or routine portfolio activity.

CFO Huntington Kelly Michelle buys 2,000 shares of MYRG at $99.50; holdings rise 377.4% to 2.5K shares

Senior VP and CFO Huntington Kelly Michelle purchased 2,000 shares (2.0K shares) at $99.50 on 2024-08-09, increasing her holdings from 530 shares to 2.5K shares post-transaction, representing a +377.4% increase in her position. The purchase occurs at a price $0.32 above the current price of $99.18 and substantially below the 52-week high of $178.21, where the stock currently trades 44.4% down from that peak. The company reported net income of $-15.3M in the latest quarter while posting annual revenue growth of +21.1%, creating an operational tension between top-line expansion and current profitability. The combination of a senior financial officer's material stake increase amid negative quarterly earnings, steeply declined stock price (-32.0% over 30 days, -35.8% over 90 days), and historically elevated valuation (P/E 33.28) warrants assessment of whether the transaction reflects confidence in near-term turnaround in profitability or other non-public context.